Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Zaccone

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
European Journal of Immunology|June 26, 1999
The involvement of IL-12 in murine experimentally induced autoimmune thyroid diseaseP Zaccone, P Hutchings, F Nicoletti, et al.
Parasite Immunology|September 13, 2006
Parasitic worms and inflammatory diseasesP Zaccone, Z Fehervari, J M Phillips, et al.
Cytokine|May 1, 1996
Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-beta treatmentF Nicoletti, F Patti, R DiMarco, et al.
Hepatology (Baltimore, Md.)|September 26, 2000
Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanismF Nicoletti, R Di Marco, P Zaccone, et al.
European Journal of Immunology|June 1, 1997
Prevention of endotoxin-induced lethality in neonatal mice by interleukin-13F Nicoletti, G Mancuso, V Cusumano, et al.
Journal of Neuroimmunology|October 1, 1996
Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosisF Nicoletti, F Patti, C Cocuzza, et al.
Autoimmunity|February 19, 2000
Concanavalin A-induced hepatitis in mice is prevented by interleukin (IL)-10 and exacerbated by endogenous IL-10 deficiencyR Di Marco, M Xiang, P Zaccone, et al.
Endocrinology|January 1, 1997
Prevention of spontaneous autoimmune diabetes in diabetes-prone BB rats by prophylactic treatment with antirat interferon-gamma antibodyF Nicoletti, P Zaccone, R Di Marco, et al.
Immunology|August 14, 1999
Endogenous interleukin-12 only plays a key pathogenetic role in non-obese diabetic mouse diabetes during the very early stages of the diseaseF Nicoletti, R Di Marco, P Zaccone, et al.
Cytokine|May 11, 2000
Essential pathogenetic role for interferon (IFN-)gamma in concanavalin A-induced T cell-dependent hepatitis: exacerbation by exogenous IFN-gamma and prevention by IFN-gamma receptor-immunoglobulin fusion proteinF Nicoletti, P Zaccone, M Xiang, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
European Journal of Immunology|June 26, 1999
The involvement of IL-12 in murine experimentally induced autoimmune thyroid diseaseP Zaccone, P Hutchings, F Nicoletti, et al.
Parasite Immunology|September 13, 2006
Parasitic worms and inflammatory diseasesP Zaccone, Z Fehervari, J M Phillips, et al.
Cytokine|May 1, 1996
Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-beta treatmentF Nicoletti, F Patti, R DiMarco, et al.
Hepatology (Baltimore, Md.)|September 26, 2000
Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanismF Nicoletti, R Di Marco, P Zaccone, et al.
European Journal of Immunology|June 1, 1997
Prevention of endotoxin-induced lethality in neonatal mice by interleukin-13F Nicoletti, G Mancuso, V Cusumano, et al.
Journal of Neuroimmunology|October 1, 1996
Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosisF Nicoletti, F Patti, C Cocuzza, et al.
Autoimmunity|February 19, 2000
Concanavalin A-induced hepatitis in mice is prevented by interleukin (IL)-10 and exacerbated by endogenous IL-10 deficiencyR Di Marco, M Xiang, P Zaccone, et al.
Endocrinology|January 1, 1997
Prevention of spontaneous autoimmune diabetes in diabetes-prone BB rats by prophylactic treatment with antirat interferon-gamma antibodyF Nicoletti, P Zaccone, R Di Marco, et al.
Immunology|August 14, 1999
Endogenous interleukin-12 only plays a key pathogenetic role in non-obese diabetic mouse diabetes during the very early stages of the diseaseF Nicoletti, R Di Marco, P Zaccone, et al.
Cytokine|May 11, 2000
Essential pathogenetic role for interferon (IFN-)gamma in concanavalin A-induced T cell-dependent hepatitis: exacerbation by exogenous IFN-gamma and prevention by IFN-gamma receptor-immunoglobulin fusion proteinF Nicoletti, P Zaccone, M Xiang, et al.
Pageof 3